Review



polyclonal anti-human tfpi antibodies  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Santa Cruz Biotechnology polyclonal anti-human tfpi antibodies
    Polyclonal Anti Human Tfpi Antibodies, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polyclonal+anti-human+tfpi+antibodies/pm31128083-59-4-11?v=Santa+Cruz+Biotechnology
    Average 90 stars, based on 1 article reviews
    polyclonal anti-human tfpi antibodies - by Bioz Stars, 2026-07
    90/100 stars

    Images



    Similar Products

    93
    R&D Systems anti human tfpi polyclonal ab
    Anti Human Tfpi Polyclonal Ab, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polyclonal+anti-human+tfpi+antibodies/pm41365435-224-13-18?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    anti human tfpi polyclonal ab - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    90
    Prolytix polyclonal sheep anti-human tfpi antibodies ahtfpi-s
    Polyclonal Sheep Anti Human Tfpi Antibodies Ahtfpi S, supplied by Prolytix, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polyclonal+anti-human+tfpi+antibodies/pm37739040-81-21-27?v=Prolytix
    Average 90 stars, based on 1 article reviews
    polyclonal sheep anti-human tfpi antibodies ahtfpi-s - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Haematologic Technologies sheep polyclonal anti-human tissue factor pathway inhibitor (tfpi) antibody
    Sheep Polyclonal Anti Human Tissue Factor Pathway Inhibitor (Tfpi) Antibody, supplied by Haematologic Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polyclonal+anti-human+tfpi+antibodies/us11723913-381-27-41?v=Haematologic+Technologies
    Average 90 stars, based on 1 article reviews
    sheep polyclonal anti-human tissue factor pathway inhibitor (tfpi) antibody - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Haematologic Technologies polyclonal sheep anti-human tfpi antibodies
    Polyclonal Sheep Anti Human Tfpi Antibodies, supplied by Haematologic Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polyclonal+anti-human+tfpi+antibodies/pmc08791571__advancesADV2021005382___suppl1-54-6-11?v=Haematologic+Technologies
    Average 90 stars, based on 1 article reviews
    polyclonal sheep anti-human tfpi antibodies - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    93
    R&D Systems polyclonal anti human tfpi antibody
    Polyclonal Anti Human Tfpi Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polyclonal+anti-human+tfpi+antibodies/us10800816-1673-14-18?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    polyclonal anti human tfpi antibody - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    93
    R&D Systems rabbit polyclonal antibody against human tfpi
    Rabbit Polyclonal Antibody Against Human Tfpi, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polyclonal+anti-human+tfpi+antibodies/us10800816-1833-14-21?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    rabbit polyclonal antibody against human tfpi - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology polyclonal anti-human tfpi antibodies
    Polyclonal Anti Human Tfpi Antibodies, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polyclonal+anti-human+tfpi+antibodies/pm31128083-59-4-11?v=Santa+Cruz+Biotechnology
    Average 90 stars, based on 1 article reviews
    polyclonal anti-human tfpi antibodies - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    93
    R&D Systems anti human tfpi goat polyclonal antibody
    Figure 2. HETE-PLs enhance thrombin generation in the absence of FIX or FXI, or in the absence of tissue factor pathway inhibitor <t>(TFPI)</t> and FVIII combined. (A and B) Thrombin generation was initiated by addition of liposomes to plasma deficient in FIX, as described in Methods. Liposomes were generated as described in Methods, and 10% 1-stearoyl-2-arachidonyl-PE (SAPE) was replaced with 10% 15-HETE-PE where indicated. (C and D) Thrombin generation was initiated by addition of liposomes to plasma deficient in FXI, as described in Methods. Liposomes were generated as described in Methods, and 10% SAPE was replaced with 10% 15-HETE-PE where indicated. (A–D) n = 3, mean ± SEM, *P < 0.05. A representative trace is shown for each. (E–H) Thrombin generation was initiated by direct addition of liposomes to plasma as described in Methods, at 10% HETE-PE, and measured in the absence (E and G) or presence (F and H) of 100 nmol/l anti-TFPI antibody preincubated for 15 minutes, in either normal (E and F) of FVIII-deficient plasma (G and H). (I–L) Thrombin generation was initiated by direct addition of liposomes to plasma as described in Methods, at 10% HETE-PC, and measured in the absence (I and K) or presence (J and L) of 80 nmol/l anti-TFPI antibody preincubated for 15 minutes, in either normal (I and J) of FVIII-deficient plasma (K and L). Data is shown as Tukey box plots, with 1-way ANOVA with Tukey post hoc multicomparison test. *P < 0.05.
    Anti Human Tfpi Goat Polyclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polyclonal+anti-human+tfpi+antibodies/pm29563336-242-0-8?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    anti human tfpi goat polyclonal antibody - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    90
    American Diagnostica rabbit polyclonal anti-human tfpi antibody
    Figure 2. HETE-PLs enhance thrombin generation in the absence of FIX or FXI, or in the absence of tissue factor pathway inhibitor <t>(TFPI)</t> and FVIII combined. (A and B) Thrombin generation was initiated by addition of liposomes to plasma deficient in FIX, as described in Methods. Liposomes were generated as described in Methods, and 10% 1-stearoyl-2-arachidonyl-PE (SAPE) was replaced with 10% 15-HETE-PE where indicated. (C and D) Thrombin generation was initiated by addition of liposomes to plasma deficient in FXI, as described in Methods. Liposomes were generated as described in Methods, and 10% SAPE was replaced with 10% 15-HETE-PE where indicated. (A–D) n = 3, mean ± SEM, *P < 0.05. A representative trace is shown for each. (E–H) Thrombin generation was initiated by direct addition of liposomes to plasma as described in Methods, at 10% HETE-PE, and measured in the absence (E and G) or presence (F and H) of 100 nmol/l anti-TFPI antibody preincubated for 15 minutes, in either normal (E and F) of FVIII-deficient plasma (G and H). (I–L) Thrombin generation was initiated by direct addition of liposomes to plasma as described in Methods, at 10% HETE-PC, and measured in the absence (I and K) or presence (J and L) of 80 nmol/l anti-TFPI antibody preincubated for 15 minutes, in either normal (I and J) of FVIII-deficient plasma (K and L). Data is shown as Tukey box plots, with 1-way ANOVA with Tukey post hoc multicomparison test. *P < 0.05.
    Rabbit Polyclonal Anti Human Tfpi Antibody, supplied by American Diagnostica, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polyclonal+anti-human+tfpi+antibodies/pm30121005-79-4-9?v=American+Diagnostica
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal anti-human tfpi antibody - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    R&D Systems antitfpi polyclonal ab
    Figure 2. HETE-PLs enhance thrombin generation in the absence of FIX or FXI, or in the absence of tissue factor pathway inhibitor <t>(TFPI)</t> and FVIII combined. (A and B) Thrombin generation was initiated by addition of liposomes to plasma deficient in FIX, as described in Methods. Liposomes were generated as described in Methods, and 10% 1-stearoyl-2-arachidonyl-PE (SAPE) was replaced with 10% 15-HETE-PE where indicated. (C and D) Thrombin generation was initiated by addition of liposomes to plasma deficient in FXI, as described in Methods. Liposomes were generated as described in Methods, and 10% SAPE was replaced with 10% 15-HETE-PE where indicated. (A–D) n = 3, mean ± SEM, *P < 0.05. A representative trace is shown for each. (E–H) Thrombin generation was initiated by direct addition of liposomes to plasma as described in Methods, at 10% HETE-PE, and measured in the absence (E and G) or presence (F and H) of 100 nmol/l anti-TFPI antibody preincubated for 15 minutes, in either normal (E and F) of FVIII-deficient plasma (G and H). (I–L) Thrombin generation was initiated by direct addition of liposomes to plasma as described in Methods, at 10% HETE-PC, and measured in the absence (I and K) or presence (J and L) of 80 nmol/l anti-TFPI antibody preincubated for 15 minutes, in either normal (I and J) of FVIII-deficient plasma (K and L). Data is shown as Tukey box plots, with 1-way ANOVA with Tukey post hoc multicomparison test. *P < 0.05.
    Antitfpi Polyclonal Ab, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/polyclonal+anti-human+tfpi+antibodies/pm28516358-91-45-48?v=R%26D+Systems
    Average 90 stars, based on 1 article reviews
    antitfpi polyclonal ab - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    Image Search Results


    Figure 2. HETE-PLs enhance thrombin generation in the absence of FIX or FXI, or in the absence of tissue factor pathway inhibitor (TFPI) and FVIII combined. (A and B) Thrombin generation was initiated by addition of liposomes to plasma deficient in FIX, as described in Methods. Liposomes were generated as described in Methods, and 10% 1-stearoyl-2-arachidonyl-PE (SAPE) was replaced with 10% 15-HETE-PE where indicated. (C and D) Thrombin generation was initiated by addition of liposomes to plasma deficient in FXI, as described in Methods. Liposomes were generated as described in Methods, and 10% SAPE was replaced with 10% 15-HETE-PE where indicated. (A–D) n = 3, mean ± SEM, *P < 0.05. A representative trace is shown for each. (E–H) Thrombin generation was initiated by direct addition of liposomes to plasma as described in Methods, at 10% HETE-PE, and measured in the absence (E and G) or presence (F and H) of 100 nmol/l anti-TFPI antibody preincubated for 15 minutes, in either normal (E and F) of FVIII-deficient plasma (G and H). (I–L) Thrombin generation was initiated by direct addition of liposomes to plasma as described in Methods, at 10% HETE-PC, and measured in the absence (I and K) or presence (J and L) of 80 nmol/l anti-TFPI antibody preincubated for 15 minutes, in either normal (I and J) of FVIII-deficient plasma (K and L). Data is shown as Tukey box plots, with 1-way ANOVA with Tukey post hoc multicomparison test. *P < 0.05.

    Journal: JCI insight

    Article Title: Enzymatically oxidized phospholipids restore thrombin generation in coagulation factor deficiencies.

    doi: 10.1172/jci.insight.98459

    Figure Lengend Snippet: Figure 2. HETE-PLs enhance thrombin generation in the absence of FIX or FXI, or in the absence of tissue factor pathway inhibitor (TFPI) and FVIII combined. (A and B) Thrombin generation was initiated by addition of liposomes to plasma deficient in FIX, as described in Methods. Liposomes were generated as described in Methods, and 10% 1-stearoyl-2-arachidonyl-PE (SAPE) was replaced with 10% 15-HETE-PE where indicated. (C and D) Thrombin generation was initiated by addition of liposomes to plasma deficient in FXI, as described in Methods. Liposomes were generated as described in Methods, and 10% SAPE was replaced with 10% 15-HETE-PE where indicated. (A–D) n = 3, mean ± SEM, *P < 0.05. A representative trace is shown for each. (E–H) Thrombin generation was initiated by direct addition of liposomes to plasma as described in Methods, at 10% HETE-PE, and measured in the absence (E and G) or presence (F and H) of 100 nmol/l anti-TFPI antibody preincubated for 15 minutes, in either normal (E and F) of FVIII-deficient plasma (G and H). (I–L) Thrombin generation was initiated by direct addition of liposomes to plasma as described in Methods, at 10% HETE-PC, and measured in the absence (I and K) or presence (J and L) of 80 nmol/l anti-TFPI antibody preincubated for 15 minutes, in either normal (I and J) of FVIII-deficient plasma (K and L). Data is shown as Tukey box plots, with 1-way ANOVA with Tukey post hoc multicomparison test. *P < 0.05.

    Article Snippet: Anti–human-TFPI goat polyclonal antibody (catalog AF2974) was from R&D Systems.

    Techniques: Liposomes, Clinical Proteomics, Generated

    Figure 3. HETE-PL restoration of hemostasis in mice lacking FVIII and enhancement of thrombin generation in FVIII deficiency, with/without tissue factor pathway inhibitor (TFPI) inhibition. (A and B) Summary data for thrombin generation in plasma as shown in Figure 3, E–L (n = 3, mean ± SEM). **P < 0.01, compared with control, as determined by 1-way ANOVA and post hoc Tukey tests. (C and D) 12-HETE-PE restores hemostasis in mice lacking FVIII. Male mice (11 weeks) were administered 78 ng HETE-PE in liposomes as described in Methods before a 3-mm tail cut. Bleeding time and Hb loss were determined as in Methods (n = 4–9 mice per group). Data is shown as Tukey box plots, with 1-way ANOVA with Tukey post hoc multicomparison test. *P < 0.05, ***P < 0.005, data shown as squares in box plot are outliers (values 1.5–3 times lower or higher than the interquartile range).

    Journal: JCI insight

    Article Title: Enzymatically oxidized phospholipids restore thrombin generation in coagulation factor deficiencies.

    doi: 10.1172/jci.insight.98459

    Figure Lengend Snippet: Figure 3. HETE-PL restoration of hemostasis in mice lacking FVIII and enhancement of thrombin generation in FVIII deficiency, with/without tissue factor pathway inhibitor (TFPI) inhibition. (A and B) Summary data for thrombin generation in plasma as shown in Figure 3, E–L (n = 3, mean ± SEM). **P < 0.01, compared with control, as determined by 1-way ANOVA and post hoc Tukey tests. (C and D) 12-HETE-PE restores hemostasis in mice lacking FVIII. Male mice (11 weeks) were administered 78 ng HETE-PE in liposomes as described in Methods before a 3-mm tail cut. Bleeding time and Hb loss were determined as in Methods (n = 4–9 mice per group). Data is shown as Tukey box plots, with 1-way ANOVA with Tukey post hoc multicomparison test. *P < 0.05, ***P < 0.005, data shown as squares in box plot are outliers (values 1.5–3 times lower or higher than the interquartile range).

    Article Snippet: Anti–human-TFPI goat polyclonal antibody (catalog AF2974) was from R&D Systems.

    Techniques: Inhibition, Clinical Proteomics, Control, Liposomes